CapsoVision (CV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.53, +1.24% vs the prior close of $6.45.
- Volume 160.78K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CV rises 1.2% to $6.53. Closed at $6.53, +1.24% vs the prior close of $6.45. Day range $6.40–$6.65, opened at $6.46.
CV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CV rises 1.2% to $6.53
- Closed at $6.53, +1.24% vs the prior close of $6.45. Day range $6.40–$6.65, opened at $6.46.
- Volume was 160.78K shares, 0.9x its 50-day average of 174.15K.
- Price is +2.7% vs its 50-day average ($6.36) and +2.2% vs its 200-day average ($6.39).
- 52-week range $4.50–$15.37; today's close sits at 19% of that range, 57.5% below the 52-week high.
Oct 15, 2026 — CV dips 2.9% to $6.45
- Closed at $6.45, -2.86% vs the prior close of $6.64. Day range $6.24–$6.75, opened at $6.69.
- Volume was 170.00K shares, 1.0x its 50-day average of 173.54K.
- Price is +1.3% vs its 50-day average ($6.37) and +0.5% vs its 200-day average ($6.42).
- 52-week range $4.46–$15.37; today's close sits at 18% of that range, 58.0% below the 52-week high.
Oct 14, 2026 — CV dips 2.1% to $6.64
- Closed at $6.64, -2.06% vs the prior close of $6.78. Day range $6.61–$6.79, opened at $6.74.
- Volume was 80.30K shares, 0.5x its 50-day average of 174.34K — lighter than usual.
- Price is +4.2% vs its 50-day average ($6.37) and +3.1% vs its 200-day average ($6.44).
- 52-week range $4.46–$15.37; today's close sits at 20% of that range, 56.8% below the 52-week high.
Oct 13, 2026 — CV ends flat (+0.3%) to $6.78
- Closed at $6.78, +0.30% vs the prior close of $6.76. Day range $6.64–$6.80, opened at $6.76.
- Volume was 86.80K shares, 0.5x its 50-day average of 174.89K — lighter than usual.
- Price is +6.3% vs its 50-day average ($6.38) and +4.7% vs its 200-day average ($6.48).
- 52-week range $4.38–$15.37; today's close sits at 22% of that range, 55.9% below the 52-week high.
Oct 12, 2026 — CV rises 2.6% to $6.76
- Closed at $6.76, +2.58% vs the prior close of $6.59. Day range $6.53–$6.81, opened at $6.54.
- Volume was 107.20K shares, 0.6x its 50-day average of 174.07K.
- Price is +5.9% vs its 50-day average ($6.39) and +3.8% vs its 200-day average ($6.51).
- 52-week range $4.38–$15.37; today's close sits at 22% of that range, 56.0% below the 52-week high.
Oct 9, 2026 — CV dips 0.5% to $6.59
- Closed at $6.59, -0.45% vs the prior close of $6.62. Day range $6.53–$6.73, opened at $6.62.
- Volume was 58.00K shares, 0.3x its 50-day average of 174.29K — lighter than usual.
- Price is +3.3% vs its 50-day average ($6.38) and +0.7% vs its 200-day average ($6.54).
- 52-week range $4.38–$15.37; today's close sits at 20% of that range, 57.1% below the 52-week high.
Oct 8, 2026 — CV rises 1.2% to $6.62
- Closed at $6.62, +1.22% vs the prior close of $6.54. Day range $6.41–$6.71, opened at $6.48.
- Volume was 91.40K shares, 0.5x its 50-day average of 174.72K — lighter than usual.
- Price is +3.7% vs its 50-day average ($6.38) and +0.7% vs its 200-day average ($6.57).
- 52-week range $4.38–$15.37; today's close sits at 20% of that range, 56.9% below the 52-week high.
Oct 7, 2026 — CV rises 0.6% to $6.54
- Closed at $6.54, +0.62% vs the prior close of $6.50. Day range $6.39–$6.58, opened at $6.39.
- Volume was 104.50K shares, 0.6x its 50-day average of 173.78K.
- Price is +2.4% vs its 50-day average ($6.38) and -1.0% vs its 200-day average ($6.61).
- 52-week range $4.38–$15.37; today's close sits at 20% of that range, 57.4% below the 52-week high.
Oct 6, 2026 — CV dips 1.3% to $6.50
- Closed at $6.50, -1.29% vs the prior close of $6.59. Day range $6.35–$6.60, opened at $6.60.
- Volume was 69.50K shares, 0.4x its 50-day average of 174.06K — lighter than usual.
- Price is +1.8% vs its 50-day average ($6.39) and -1.9% vs its 200-day average ($6.63).
- 52-week range $4.38–$15.37; today's close sits at 19% of that range, 57.7% below the 52-week high.
Oct 5, 2026 — CV jumps 6.7% to $6.59
- Closed at $6.59, +6.73% vs the prior close of $6.17. Day range $6.11–$6.61, opened at $6.13.
- Volume was 90.40K shares, 0.5x its 50-day average of 173.66K — lighter than usual.
- Price is +3.1% vs its 50-day average ($6.39) and -1.1% vs its 200-day average ($6.66).
- 52-week range $4.38–$15.37; today's close sits at 20% of that range, 57.2% below the 52-week high.
Oct 2, 2026 — CV dips 2.4% to $6.17, 4 down days in a row
- Closed at $6.17, -2.37% vs the prior close of $6.32. Day range $6.12–$6.40, opened at $6.35.
- Volume was 128.70K shares, 0.7x its 50-day average of 173.28K.
- Price is -3.4% vs its 50-day average ($6.39) and -7.7% vs its 200-day average ($6.68).
- 52-week range $4.38–$15.37; today's close sits at 16% of that range, 59.9% below the 52-week high.
- That makes 4 straight losses.
CV latest news & SEC filings
Every SEC filing by or about CV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Harari Eliyahou Et Al bought 878,735 shares at $5.69 (≈$5.00M) on Sep 18, 2026; now holds 1,396,494
- Harari Eliyahou Et Al bought 878,734 shares at $5.69 (≈$5.00M) on Sep 18, 2026; now holds 878,734
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Shen Ching Hang reported an other transaction of 3,991,606 shares on Apr 17, 2026
- Shen Ching Hang reported an other transaction of 3,991,606 shares on Apr 17, 2026; now holds 6,400,527
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Shen Ching Hang bought 878,734 shares at $5.69 (≈$5.00M) on Sep 15, 2026; now holds 7,279,261
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Shen Ching Hang bought 878,734 shares at $5.69 (≈$5.00M) on Sep 15, 2026; now holds 2,926,655
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 18, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 21, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 21, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $3.64M (prior year $3.31M) (+9.9% vs Jun 30, 2025)
- Net income: -$7.48M (prior year -$4.62M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.15 (prior year -$2.02) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Harari Eliyahou Et Al bought 61,068 shares at $6.73 (≈$410.99K) on Jul 17, 2026
- Harari Eliyahou Et Al bought 61,068 shares at $6.73 (≈$410.99K) on Jul 17, 2026
- Harari Eliyahou Et Al bought 61,068 shares at $6.73 (≈$410.99K) on Jul 17, 2026
- Harari Eliyahou Et Al bought 61,068 shares at $6.73 (≈$410.99K) on Jul 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Harari Eliyahou Et Al bought 81,300 shares at $6.09 (≈$495.12K) on Jul 8, 2026
- Harari Eliyahou Et Al bought 81,300 shares at $6.09 (≈$495.12K) on Jul 8, 2026
- Harari Eliyahou Et Al bought 81,300 shares at $6.09 (≈$495.12K) on Jul 8, 2026
- Harari Eliyahou Et Al bought 81,300 shares at $6.09 (≈$495.12K) on Jul 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade CV
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 26, 2026, Mar 20, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.89% (largest 7.8%).
- Liquidity: about 167.35K shares (≈$1.09M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $6.53 vs a range of $4.50–$15.37 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Eliyahou Et Al Harari bought 878,734 shares on Sep 18, 2026.
- Latest filings: 8-K Sep 28, 2026; 8-K Sep 18, 2026; 8-K Aug 18, 2026.
- Share count: 50.05M shares outstanding (Aug 12, 2026), +7.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
CV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.46 | 6.65 | 6.40 | 6.53 | 160.78K |
| Oct 15, 2026 | 6.69 | 6.75 | 6.24 | 6.45 | 170.00K |
| Oct 14, 2026 | 6.74 | 6.79 | 6.61 | 6.64 | 80.30K |
| Oct 13, 2026 | 6.76 | 6.80 | 6.64 | 6.78 | 86.80K |
| Oct 12, 2026 | 6.54 | 6.81 | 6.53 | 6.76 | 107.20K |
| Oct 9, 2026 | 6.62 | 6.73 | 6.53 | 6.59 | 58.00K |
| Oct 8, 2026 | 6.48 | 6.71 | 6.41 | 6.62 | 91.40K |
| Oct 7, 2026 | 6.39 | 6.58 | 6.39 | 6.54 | 104.50K |
| Oct 6, 2026 | 6.60 | 6.60 | 6.35 | 6.50 | 69.50K |
| Oct 5, 2026 | 6.13 | 6.61 | 6.11 | 6.59 | 90.40K |
| Oct 2, 2026 | 6.35 | 6.40 | 6.12 | 6.17 | 128.70K |
| Oct 1, 2026 | 6.40 | 6.54 | 6.25 | 6.32 | 159.40K |
| Sep 30, 2026 | 6.72 | 6.79 | 6.37 | 6.46 | 155.30K |
| Sep 29, 2026 | 6.90 | 6.98 | 6.55 | 6.69 | 245.00K |
| Sep 28, 2026 | 6.60 | 6.94 | 6.50 | 6.92 | 352.70K |
| Sep 25, 2026 | 6.18 | 6.69 | 6.17 | 6.65 | 184.60K |
| Sep 24, 2026 | 6.05 | 6.19 | 5.88 | 6.17 | 216.90K |
| Sep 23, 2026 | 6.26 | 6.32 | 6.03 | 6.05 | 443.20K |
| Sep 22, 2026 | 6.25 | 6.33 | 6.00 | 6.30 | 271.80K |
| Sep 21, 2026 | 6.91 | 6.91 | 6.07 | 6.19 | 170.60K |
About CapsoVision
CapsoVision (CV) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in SARATOGA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1378325.
CV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Julia S Gouw | Director | Jul 1, 2026 |
| Michele Harari | Director | Jul 1, 2026 |
| Joanne Carol Imperial | Director | Jul 1, 2026 |
| Wen-Herng Henry King | Director | Jul 1, 2026 |
| Hui Ying Kuo | Director | Jul 1, 2026 |
| David Stanley Shields | Director | Jul 2, 2026 |
| Chen Lung Tsai | Director | Jul 1, 2026 |
| Kang-Huai Wang | See Remarks | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Douglas Patrick Atkinson | Head of Global Sales | Jun 3, 2026 |
| David Michael Garcia | Sr. VP of Finance | Jun 3, 2026 |
| Kang-Huai Wang | See Remarks | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,734 | $5.69 |
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,735 | $5.69 |
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,734 | $5.69 |
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,735 | $5.69 |
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,734 | $5.69 |
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,735 | $5.69 |
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,734 | $5.69 |
| Sep 18, 2026 | Eliyahou Et Al Harari | Buy | 878,735 | $5.69 |
| Sep 15, 2026 | Ching Hang Shen | Buy | 878,734 | $5.69 |
| Sep 15, 2026 | Ching Hang Shen | Buy | 878,734 | $5.69 |
| Sep 15, 2026 | Ching Hang Shen | Buy | 878,734 | $5.69 |
| Sep 15, 2026 | Ching Hang Shen | Buy | 878,734 | $5.69 |
| Sep 15, 2026 | Ching Hang Shen | Buy | 878,734 | $5.69 |
| Sep 15, 2026 | Ching Hang Shen | Buy | 878,734 | $5.69 |
| Sep 15, 2026 | Ching Hang Shen | Buy | 878,734 | $5.69 |
CV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $13.55M | $-25.32M | -1.03 | $-22.86M |
| Dec 31, 2024 | $11.76M | $-19.90M | -9.85 | $-20.09M |
Latest balance sheet: total assets $18.57M, total liabilities $5.40M, cash $— (as of Jun 30, 2026).
CV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $6.79 |
| May 14, 2026 | 8-K Item 2.02 (results) | $7.30 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $7.53 |
| Mar 20, 2026 | 8-K Item 2.02 (results) | $6.87 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $5.67 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $4.02 |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.